Chargement en cours...
Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
Epigenetic therapies such as histone deacetylase inhibitors (HDACi) not only have the capability to decrease tumor cell proliferation and to induce tumor cell death but also to silence antiviral response genes. Here, we investigated whether the combination of an oncolytic measles vaccine virus (MeV)...
Enregistré dans:
| Publié dans: | Mol Ther Oncolytics |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782956/ https://ncbi.nlm.nih.gov/pubmed/27119111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.19 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|